Your browser doesn't support javascript.
loading
Multi-Imaging Characterization of Cardiac Phenotype in Different Types of Amyloidosis.
Ioannou, Adam; Patel, Rishi K; Razvi, Yousuf; Porcari, Aldostefano; Knight, Daniel; Martinez-Naharro, Ana; Kotecha, Tushar; Venneri, Lucia; Chacko, Liza; Brown, James; Manisty, Charlotte; Moon, James; Wisniowski, Brendan; Lachmann, Helen; Wechelakar, Ashutosh; Whelan, Carol; Kellman, Peter; Hawkins, Philip N; Gillmore, Julian D; Fontana, Marianna.
Afiliação
  • Ioannou A; National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom.
  • Patel RK; National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom.
  • Razvi Y; National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom.
  • Porcari A; National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom.
  • Knight D; National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom.
  • Martinez-Naharro A; National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom.
  • Kotecha T; National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom.
  • Venneri L; National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom.
  • Chacko L; National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom.
  • Brown J; National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom.
  • Manisty C; St Bartholomew's Hospital, London, United Kingdom.
  • Moon J; St Bartholomew's Hospital, London, United Kingdom.
  • Wisniowski B; National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom.
  • Lachmann H; National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom.
  • Wechelakar A; National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom.
  • Whelan C; National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom.
  • Kellman P; National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Hawkins PN; National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom.
  • Gillmore JD; National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom.
  • Fontana M; National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom. Electronic address: m.fontana@ucl.ac.uk.
JACC Cardiovasc Imaging ; 16(4): 464-477, 2023 04.
Article em En | MEDLINE | ID: mdl-36648052
ABSTRACT

BACKGROUND:

Bone scintigraphy is extremely valuable when assessing patients with suspected cardiac amyloidosis (CA), but the clinical significance and associated phenotype of different degrees of cardiac uptake across different types is yet to be defined.

OBJECTIVES:

This study sought to define the phenotypes of patients with varying degrees of cardiac uptake on bone scintigraphy, across multiple types of systemic amyloidosis, using extensive characterization comprising biomarkers as well as echocardiographic and cardiac magnetic resonance (CMR) imaging.

METHODS:

A total of 296 patients (117 with immunoglobulin light-chain amyloidosis [AL], 165 with transthyretin amyloidosis [ATTR], 7 with apolipoprotein AI amyloidosis [AApoAI], and 7 with apolipoprotein AIV amyloidosis [AApoAIV]) underwent deep characterization of their cardiac phenotype.

RESULTS:

AL patients with grade 0 myocardial radiotracer uptake spanned the spectrum of CMR findings from no CA to characteristic CA, whereas AL patients with grades 1 to 3 always produced characteristic CMR features. In ATTR, the CA burden strongly correlated with myocardial tracer uptake, except in Ser77Tyr. AApoAI presented with grade 0 or 1 and disproportionate right-sided involvement. AApoAIV always presented with grade 0 and characteristic CA. AL grade 1 patients (n = 48; 100%) had characteristic CA, whereas only ATTR grade 1 patients with Ser77Tyr had characteristic CA on CMR (n = 5; 11.4%). After exclusion of Ser77Tyr, AApoAI, and AApoAIV, CMR showing characteristic CA or an extracellular volume of >0.40 in patients with grade 0 to 1 cardiac uptake had a sensitivity and specificity of 100% for AL.

CONCLUSIONS:

There is a wide variation in cardiac phenotype between different amyloidosis types across different degrees of cardiac uptake. The combination of CMR and bone scintigraphy can help to define the diagnostic differentials and the clinical phenotype in each individual patient.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neuropatias Amiloides Familiares / Amiloidose de Cadeia Leve de Imunoglobulina / Cardiomiopatias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: JACC Cardiovasc Imaging Assunto da revista: ANGIOLOGIA / CARDIOLOGIA / DIAGNOSTICO POR IMAGEM Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neuropatias Amiloides Familiares / Amiloidose de Cadeia Leve de Imunoglobulina / Cardiomiopatias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: JACC Cardiovasc Imaging Assunto da revista: ANGIOLOGIA / CARDIOLOGIA / DIAGNOSTICO POR IMAGEM Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido